Raman Singh logo

Raman Singh

Asia, Singapore

Description

Raman Singh is CEO at Juniper Biologics. He attended Thunderbird School of Global Management.

Investor Profile

Raman Singh has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Singapore.
  • Strong thematic focus on Biotechnology, Life Science.

Stage Focus

  • Series A (100%)

Country Focus

  • Singapore (100%)

Industry Focus

  • Biotechnology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Raman Singh frequently co-invest with?

Eisai
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Openspace
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1

Which angels does Raman Singh often collaborate with?

Wendou Niu
Asia, Singapore
Shared Deals: 1
KS
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Raman Singh?

Neuroglee Therapeutics

Singapore, Central Region, Singapore

Neuroglee Therapeutics is a digital therapeutic platform created to treat patients in the early stages of the disease.

BiotechnologyLife Science
Series ASep 9, 2021
Amount Raised: $10,000,000